CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-06-04 | Patel Sunil Director | Grant or award · Non-Qualified Stock Option (right to buy) | +3,312 | $67.53 | $224K | 3,312 |
| 2014-05-27 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −4,667 | $66.89 | $312K | 26,978 |
| 2014-05-27 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +347 | $9.96 | $3K | 27,325 |
| 2014-05-27 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −347 | $66.93 | $23K | 26,978 |
| 2014-05-27 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +1,666 | $21.92 | $37K | 28,644 |
| 2014-05-27 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −1,666 | $66.93 | $112K | 26,978 |
| 2014-05-27 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +486 | $14.47 | $7K | 27,464 |
| 2014-05-27 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −486 | $66.93 | $33K | 26,978 |
| 2014-05-27 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Employee Stock Option (right to buy) | −486 | 1,134 | ||
| 2014-05-27 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −347 | 0 | ||
| 2014-05-27 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −1,666 | 8,894 | ||
| 2014-03-25 | BVF PARTNERS L P/IL | Sale | −18,019 | $69.95 | $1.3M | 230,125 |
| 2014-03-25 | BVF PARTNERS L P/IL | Sale | −10,203 | $69.95 | $714K | 130,175 |
| 2014-03-24 | BVF PARTNERS L P/IL | Sale | −31,698 | $70.17 | $2.2M | 248,144 |
| 2014-03-24 | BVF PARTNERS L P/IL | Sale | −18,306 | $70.17 | $1.3M | 140,378 |
| 2014-03-19 | Davis Todd C Director | Sale | −5,000 | $79.63 | $398K | 32,536 |
| 2014-03-18 | Davis Todd C Director | Sale | −2,500 | $79.45 | $199K | 37,536 |
| 2014-03-18 | LAMATTINA JOHN L Director | Exercise or conversion | +5,000 | $8.97 | $45K | 26,356 |
| 2014-03-18 | LAMATTINA JOHN L Director | Sale | −5,000 | $78.83 | $394K | 21,356 |
| 2014-03-18 | LAMATTINA JOHN L Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −5,000 | 0 |
Page 74 of 86 · 1,712 trades